• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机模拟、多光谱和显微镜研究观察到,PI3K/mTOR 双重抑制剂匹地利昔布稳定结合人血清白蛋白的 I 位点。

PI3K/mTOR Dual Inhibitor Pictilisib Stably Binds to Site I of Human Serum Albumin as Observed by Computer Simulation, Multispectroscopic, and Microscopic Studies.

机构信息

College of Life Sciences, Northwest Normal University, Lanzhou 730070, China.

出版信息

Molecules. 2022 Aug 9;27(16):5071. doi: 10.3390/molecules27165071.

DOI:10.3390/molecules27165071
PMID:36014303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9413508/
Abstract

Pictilisib (GDC-0941) is a well-known dual inhibitor of class I PI3K and mTOR and is presently undergoing phase 2 clinical trials for cancer treatment. The present work investigated the dynamic behaviors and interaction mechanism between GDC-0941 and human serum albumin (HSA). Molecular docking and MD trajectory analyses revealed that GDC-0941 bound to HSA and that the binding site was positioned in subdomain IIA at Sudlow's site I of HSA. The fluorescence intensity of HSA was strongly quenched by GDC-0941, and results showed that the HSA-GDC-0941 interaction was a static process caused by ground-state complex formation. The association constant of the HSA-GDC-0941 complex was approximately 10 M, reflecting moderate affinity. Thermodynamic analysis conclusions were identical with MD simulation results, which revealed that van der Waals interactions were the vital forces involved in the binding process. CD, synchronous, and 3D fluorescence spectroscopic results revealed that GDC-0941 induced the structural change in HSA. Moreover, the conformational change of HSA affected its molecular sizes, as evidenced by AFM. This work provides a useful research strategy for exploring the interaction of GDC-0941 with HSA, thus helping in the understanding of the transport and delivery of dual inhibitors in the blood circulation system.

摘要

皮克替利昔布(GDC-0941)是一种著名的 I 类 PI3K 和 mTOR 双重抑制剂,目前正在进行癌症治疗的 2 期临床试验。本工作研究了 GDC-0941 与人血清白蛋白(HSA)之间的动态行为和相互作用机制。分子对接和 MD 轨迹分析表明,GDC-0941 与 HSA 结合,结合位点位于 HSA 的亚结构域 IIA 中的 Sudlow 位点 I。GDC-0941 强烈猝灭 HSA 的荧光强度,结果表明 HSA-GDC-0941 相互作用是由基态复合物形成引起的静态过程。HSA-GDC-0941 复合物的结合常数约为 10 M,反映出中等亲和力。热力学分析结论与 MD 模拟结果一致,表明范德华相互作用是结合过程中的重要力。CD、同步和 3D 荧光光谱结果表明 GDC-0941 诱导 HSA 的结构变化。此外,HSA 的构象变化影响其分子大小,这一点可以通过 AFM 得到证明。这项工作为探索 GDC-0941 与 HSA 的相互作用提供了有用的研究策略,有助于理解双重抑制剂在血液循环系统中的转运和递送。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/baa951591a71/molecules-27-05071-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/f88c3570ea29/molecules-27-05071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/fb22558a7041/molecules-27-05071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/dd78ea57d867/molecules-27-05071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/9a34cc35dc99/molecules-27-05071-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/0b455305e0e3/molecules-27-05071-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/def213862c95/molecules-27-05071-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/0d4fbe8d96e5/molecules-27-05071-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/f090468470bc/molecules-27-05071-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/8e6b33be0cd2/molecules-27-05071-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/baa951591a71/molecules-27-05071-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/f88c3570ea29/molecules-27-05071-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/fb22558a7041/molecules-27-05071-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/dd78ea57d867/molecules-27-05071-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/9a34cc35dc99/molecules-27-05071-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/0b455305e0e3/molecules-27-05071-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/def213862c95/molecules-27-05071-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/0d4fbe8d96e5/molecules-27-05071-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/f090468470bc/molecules-27-05071-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/8e6b33be0cd2/molecules-27-05071-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/444d/9413508/baa951591a71/molecules-27-05071-g010.jpg

相似文献

1
PI3K/mTOR Dual Inhibitor Pictilisib Stably Binds to Site I of Human Serum Albumin as Observed by Computer Simulation, Multispectroscopic, and Microscopic Studies.计算机模拟、多光谱和显微镜研究观察到,PI3K/mTOR 双重抑制剂匹地利昔布稳定结合人血清白蛋白的 I 位点。
Molecules. 2022 Aug 9;27(16):5071. doi: 10.3390/molecules27165071.
2
Interaction of novel Aurora kinase inhibitor MK-0457 with human serum albumin: Insights into the dynamic behavior, binding mechanism, conformation and esterase activity of human serum albumin.新型 Aurora 激酶抑制剂 MK-0457 与人血清白蛋白的相互作用:对人血清白蛋白的动态行为、结合机制、构象和酯酶活性的深入了解。
J Pharm Biomed Anal. 2020 Jan 30;178:112962. doi: 10.1016/j.jpba.2019.112962. Epub 2019 Nov 4.
3
Study on the interaction of two quinazoline derivatives as novel PI3K/mTOR dual inhibitors and anticancer agents to human serum albumin utilizing spectroscopy and docking.利用光谱和对接研究两种新型喹唑啉衍生物作为 PI3K/mTOR 双重抑制剂和抗癌剂与人血清白蛋白的相互作用。
Luminescence. 2023 Mar;38(3):260-268. doi: 10.1002/bio.4444. Epub 2023 Jan 23.
4
Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach.抗癌药物帕唑帕尼与人血清白蛋白的生物分子相互作用机制:一种多光谱和计算方法。
J Biomol Struct Dyn. 2022 Nov;40(18):8312-8323. doi: 10.1080/07391102.2021.1911850. Epub 2021 Apr 19.
5
Characterization of sulfasalazine-bovine serum albumin and human serum albumin interaction by spectroscopic and theoretical approach.采用光谱学和理论方法研究柳氮磺胺吡啶-牛血清白蛋白和人血清白蛋白的相互作用。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Nov 5;300:122865. doi: 10.1016/j.saa.2023.122865. Epub 2023 May 16.
6
Spectroscopy and molecular simulation on the interaction of Nano-Kaempferol prepared by oil-in-water with two carrier proteins: An investigation of protein-protein interaction.水包油法制备纳科拉非醇与两种载体蛋白相互作用的光谱学和分子模拟:蛋白质-蛋白质相互作用的研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2024 Mar 15;309:123815. doi: 10.1016/j.saa.2023.123815. Epub 2023 Dec 24.
7
Exploring the combination characteristics of lumefantrine, an antimalarial drug and human serum albumin through spectroscopic and molecular docking studies.通过光谱和分子对接研究探索抗疟药物青蒿琥酯与人血清白蛋白的结合特性。
J Biomol Struct Dyn. 2021 Feb;39(2):691-702. doi: 10.1080/07391102.2020.1713215. Epub 2020 Jan 22.
8
Deciphering the binding site and mechanism of new methylene blue with serum albumins: A multispectroscopic and computational investigation.解析新型亚甲蓝与血清白蛋白的结合部位和机制:多光谱和计算研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Nov 5;300:122900. doi: 10.1016/j.saa.2023.122900. Epub 2023 May 20.
9
Evaluating the biomolecular interaction between delamanid/formulations and human serum albumin by fluorescence, CD spectroscopy and SPR: Effects on protein conformation, kinetic and thermodynamic parameters.通过荧光、圆二色光谱和 SPR 评估德拉马尼/制剂与人血清白蛋白的生物分子相互作用:对蛋白质构象、动力学和热力学参数的影响。
Colloids Surf B Biointerfaces. 2024 Jul;239:113964. doi: 10.1016/j.colsurfb.2024.113964. Epub 2024 May 14.
10
Probing the binding mechanism of capecitabine to human serum albumin using spectrometric methods, molecular modeling, and chemometrics approach.运用光谱法、分子建模和化学计量学方法探究卡培他滨与人血清白蛋白的结合机制。
Bioorg Chem. 2019 Sep;90:103037. doi: 10.1016/j.bioorg.2019.103037. Epub 2019 Jun 8.

引用本文的文献

1
Exploring the binding interaction of 1,4-naphthoquinone derivative-human serum albumin complex by biophysics and molecular simulation.通过生物物理学和分子模拟探索1,4-萘醌衍生物-人血清白蛋白复合物的结合相互作用
Sci Rep. 2025 Jun 2;15(1):19249. doi: 10.1038/s41598-025-02787-1.
2
Design, synthesis and biological evaluation of novel morpholinopyrimidine-5-carbonitrile derivatives as dual PI3K/mTOR inhibitors.新型吗啉代嘧啶-5-腈衍生物作为双靶点PI3K/mTOR抑制剂的设计、合成及生物学评价
RSC Med Chem. 2024 Feb 2;15(2):733-752. doi: 10.1039/d3md00693j. eCollection 2024 Feb 21.

本文引用的文献

1
Investigating the Effect of Tyrosine Kinase Inhibitors on the Interaction between Human Serum Albumin by Atomic Force Microscopy.用原子力显微镜研究酪氨酸激酶抑制剂对人血清白蛋白相互作用的影响。
Biomolecules. 2022 Jun 11;12(6):819. doi: 10.3390/biom12060819.
2
Spectroscopic demonstration of sinapic acid methyl ester complexes with serum albumins.芥子酸甲酯与血清白蛋白复合物的光谱学证明
RSC Adv. 2020 Feb 28;10(15):8810-8820. doi: 10.1039/c9ra09980h. eCollection 2020 Feb 27.
3
Conformational stability as a quality attribute for the cell therapy raw material human serum albumin.
作为细胞治疗原料人血清白蛋白质量属性的构象稳定性。
RSC Adv. 2021 Apr 23;11(25):15332-15339. doi: 10.1039/d1ra01064f. eCollection 2021 Apr 21.
4
Experimental and Computational Investigation on the Interaction of Anticancer Drug Gemcitabine with Human Plasma Protein: Effect of Copresence of Ibuprofen on the Binding.抗癌药物吉西他滨与人血浆蛋白相互作用的实验和计算研究:布洛芬共存对结合的影响。
Molecules. 2022 Mar 1;27(5):1635. doi: 10.3390/molecules27051635.
5
Interactions between Human Serum Albumin and Sulfadimethoxine Determined Using Spectroscopy and Molecular Docking.利用光谱学和分子对接技术测定人血清白蛋白与磺胺二甲氧嘧啶之间的相互作用
Molecules. 2022 Feb 24;27(5):1526. doi: 10.3390/molecules27051526.
6
Study on the interaction between 2,6-dihydroxybenzoic acid nicotine salt and human serum albumin by multi-spectroscopy and molecular dynamics simulation.2,6-二羟基苯甲酸烟碱盐与人血清白蛋白相互作用的多光谱及分子动力学模拟研究。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Apr 5;270:120868. doi: 10.1016/j.saa.2022.120868. Epub 2022 Jan 10.
7
Dual Inhibition of Histone Deacetylases and the Mechanistic Target of Rapamycin Promotes Apoptosis in Cell Line Models of Uveal Melanoma.双重抑制组蛋白去乙酰化酶和雷帕霉素的作用靶点促进葡萄膜黑素瘤细胞系模型中的细胞凋亡。
Invest Ophthalmol Vis Sci. 2021 Sep 2;62(12):16. doi: 10.1167/iovs.62.12.16.
8
Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer.靶向乳腺癌中的PI3K/AKT/mTOR信号通路
Cancers (Basel). 2021 Jul 14;13(14):3517. doi: 10.3390/cancers13143517.
9
PI3K/mTOR Dual Inhibitor PF-04691502 Is a Schedule-Dependent Radiosensitizer for Gastroenteropancreatic Neuroendocrine Tumors.PI3K/mTOR 双重抑制剂 PF-04691502 是一种依赖于时间表的胃肠胰腺神经内分泌肿瘤放射增敏剂。
Cells. 2021 May 20;10(5):1261. doi: 10.3390/cells10051261.
10
How hydrophilic group affects drug-protein binding modes: Differences in interaction between sirtuins inhibitors Tenovin-1/Tenovin-6 and human serum albumin.亲水基团如何影响药物-蛋白结合模式:Sirtuins 抑制剂 Tenovin-1/Tenovin-6 与人血清白蛋白相互作用的差异。
J Pharm Biomed Anal. 2021 Jul 15;201:114121. doi: 10.1016/j.jpba.2021.114121. Epub 2021 May 7.